Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Heluo Shugan Pian is a Traditional Chinese Medicine (TCM) herbal formulation developed and manufactured by Shaanxi Momentum Pharmaceutical (also known as Shaanxi Momentum Qixuehe Pharmaceutical). The formulation consists of 27 herbal ingredients, including prepared Cyperus rotundus, turmeric, Sanleng, Bupleurum, Radix Paeoniae, Angelica, prepared Polygonum multiflorum, and Polygonum cuspidatum. It is primarily indicated for the treatment of chronic hepatitis and early-stage liver cirrhosis. Its therapeutic actions, described within the framework of TCM, include soothing the liver and regulating qi, clearing damp-heat, promoting blood circulation to remove blood stasis, and nourishing the liver and kidneys. As a complex herbal mixture, it functions through multiple pharmacological pathways rather than a single molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Heluo Shugan Pian.